Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tishi Shah
Observed name:
Shah, Tishi
Institutions:
Boston Children's Hospital,
Harvard University,
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Observed institutions:
Boston Children's Hospital,
Saint Peter's University Hospital,
Harvard University,
New York Medical College,
University of Alabama at Birmingham,
Dana-Farber/Boston Children's Cancer and Blood Disorders Center,
UAB Medicine
show all 7
OpenAlex ID:
A5046471721
The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL
2017
·
Sanghoon Lee
, Wen Luo
, et al.
·
Oncotarget
·
35
PDF
Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model
2018
·
Sanghoon Lee
, Tishi Shah
, et al.
·
Oncotarget
·
24
PDF
Ibrutinib significantly inhibited Bruton’s tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model
2018
·
Yaya Chu
, Sanghoon Lee
, et al.
·
OncoImmunology
·
22
PDF
Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy
2014
·
Sameer Sait
, Nibal Zaghloul
, et al.
·
Pediatric Blood & Cancer
·
19
Gene expression patterns in peripheral blood cells associated with radiographic severity in African Americans with early rheumatoid arthritis
2012
·
CLEAR Investigators
, Richard J. Reynolds
, et al.
·
Rheumatology International
·
15
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL
2020
·
Yaya Chu
, Aradhana Awasthi
, et al.
·
Oncotarget
·
10
PDF
Fetal therapy with mTOR inhibitors in cardiac rhabdomyoma and lymphatic malformations
2025
·
Nikan Zargarzadeh
, Pegah Rashidian
, et al.
·
Best Practice & Research Clinical Obstetrics & Gynaecology
·
2
Practice Variations in Managing Infantile Hemangiomas
2023
·
Thomas W. McLean
, Alexandra J. Borst
, et al.
·
Journal of Pediatric Hematology/Oncology
·
1
PDF
Medical Management of Vascular Anomalies
2026
·
Tishi Shah
, Denise M. Adams
·
Clinics in Plastic Surgery
Hemophagocytic lymphohistiocytosis: new grading classification and targeted therapies.
2026
·
Edo Schaefer
, Tishi Shah
, et al.
·
PubMed
Treatment of Vascular Anomalies With Sirolimus: Characterizing Practice Patterns of US Specialist Clinicians
2026
·
Bryan A. Sisk
, Stephanie Milam
, et al.
·
Pediatric Blood & Cancer
Hematologic Complications After Epiphysiodesis for Vascular Malformation-Related Leg-Length Discrepancy: A Retrospective Cohort Study
2026
·
Besiana P. Beqo
, Amanda Thompson
, et al.
·
Journal of Vascular Anomalies
Cutaneous adverse events associated with mitogen activated protein kinase inhibitors for the treatment of vascular anomalies: A dual-center retrospective study
2025
·
Isabella R. Plumptre
, Racquel A. Bitar
, et al.
·
Journal of the American Academy of Dermatology
Patient and Caregiver Perspectives on Clinical Care, Comprehensive Support, and Communication in Langerhans Cell Histiocytosis Management
2025
·
Jeffrey G. Edwards
, Michael R. Jeng
, et al.
·
Pediatric Blood & Cancer
Metastatic neuroblastoma at young age in Sotos syndrome - consideration of routine tumor screening
2021
·
Elise Bergin
, Neel Madan
, et al.
·
Molecular Genetics and Metabolism
Abstract 2657: PD-L1 blockade enhances T cell cytotoxicity against primary mediastinal B cell lymphoma
2017
·
Tishi Shah
, Wen Luo
, et al.
·
Cancer Research
Safety & Efficacy of Liposomal Amphotericin B Followed By Micafungin to Prevent Invasive Fungal Infection in Pediatric Allogeneic Stem Cell Transplantation Recipients
2017
·
Tishi Shah
, Mona Elmacken
, et al.
·
Transplantation and Cellular Therapy
Abstract 3838: Upregulation of DLEU1 significantly prolongs survival in a rituximab-treated DLEU1 knockout human Burkitt lymphoma (BL) xenograft NSG mouse model: DLEU1 may act as a tumor suppressor gene in pediatric BL
2016
·
Sanghoon Lee
, Changhong Yin
, et al.
·
Cancer Research
Show more works
View as search
Works count:
19
Citation count:
128
H-index:
6
I10-index:
6
Year
Topic
Type